Form 8-K - Current report:
SEC Accession No. 0000950170-25-076911
Filing Date
2025-05-23
Accepted
2025-05-23 16:06:08
Documents
10
Period of Report
2025-05-23
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bold-20250523.htm   iXBRL 8-K 52651
  Complete submission text file 0000950170-25-076911.txt   165793

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20250523.xsd EX-101.SCH 25994
12 EXTRACTED XBRL INSTANCE DOCUMENT bold-20250523_htm.xml XML 4931
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 25982163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)